| Madeline Lehane Irving, | |
|
108 Post Rd, Alamo, CA 94507-2619 | |
| (925) 642-2618 | |
| Not Available |
| Full Name | Madeline Lehane Irving |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 108 Post Rd, Alamo, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154796191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madeline Lehane Irving, 108 Post Rd, Alamo, CA 94507-2619 Ph: (925) 642-2618 | Madeline Lehane Irving, 108 Post Rd, Alamo, CA 94507-2619 Ph: (925) 642-2618 |
News Archive
Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues.
Merck, known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company's investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA's pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
› Verified 8 days ago
Mrs. Kaitlin Walker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1396 Danville Blvd Apt 208, Alamo, CA 94507 Phone: 925-396-5975 | |
Ms. Nancy Craig Joyce, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 19 Orchard Ct, Alamo, CA 94507 Phone: 925-286-6580 Fax: 925-938-5587 |